Evidence map›Paper›PMID 26472032›Full record

ArticleOncotarget2015

microRNAs calibrate T cell responses by regulating mTOR.

Matthias Merkenschlager, Antoine Marcais

Open access · diamondAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Matthias MerkenschlagerMRC Clinical Sciences Centre, Imperial College London, London, UK.
Antoine MarcaisCIRI, International Center for Infectiology Research, Université de Lyon, Inserm, CNRS, Ecole Normale Supérieure, Lyon, France.
Imperial College London · GBInserm · FR

Funding

Medical Research Council MC_U120027516
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DEAD-box RNA HelicasesGene Expression RegulationHumansLymphocyte ActivationMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MicroRNAsMultiprotein ComplexesReceptors, Antigen, T-CellRibonuclease IIIRNA, MessengerT-LymphocytesTOR Serine-Threonine KinasesDEAD-box RNA HelicasesDICER1 protein, humanMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MicroRNAsMTOR protein, humanMultiprotein ComplexesReceptors, Antigen, T-CellRibonuclease IIIRNA, MessengerTOR Serine-Threonine Kinasesanergyinterleukin-2microRNAmTORT cell activation

Identifiers

PMID26472032
PMCPMC4741431
OpenAlexW2252915887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.